Header image

Session F: Integration of HCV, other Co-Infections and Harm Reduction Services (CHAFEA Sponsored Session)

Tracks
.
Wednesday, September 19, 2018
4:15 PM - 5:45 PM
Sala XII + XIII

Speaker

Jean Luc Sion
DG SANTE

What does the EU mean by “integrated” infectious disease programmes and what policy developments have there been to further this agenda?

4:15 PM - 4:20 PM

Biography

Agenda Item Image
Mr João Goulão
General Director
SICAD

Integration of HCV, Other Co-Infections and Harm Reduction Services for People Who Inject Drugs in Portugal

4:20 PM - 4:25 PM

Speaker Presentation

Biography

Mrs Dagmar Hedrich
Consultant
Freelance

How do EU agencies take an integrated approach to hepatitis C control

4:25 PM - 4:35 PM

Speaker Presentation

Video Recording

Biography

Agenda Item Image
Dr Viktor Mravčík
Researcher
National Monitoring Centre For Drugs And Addiction, Office Of The Government, The Czech Republic

Best Practice Model from a Czech Republic Prison

4:35 PM - 4:45 PM

Speaker Presentation

Video Recording

Biography

Agenda Item Image
Dr John (Jack) Lambert
Consultant In Infectious Diseases, Medicine And Sexual Health (gum)
UCD/ Mater Misericordiae University Hospital Catherine Mc Auley Education & Research Centre, Dublin, Ireland

Transitioning specialist HCV services into the community

4:45 PM - 5:00 PM

Speaker Presentation

Video Recording

Biography

Alistair Story
E-DETECT

Transitioning specialist HCV services into the community

4:45 PM - 5:00 PM

Video Recording

Biography

Dr Raquel Duarte
Researcher
Centro De Diagnóstico Pneumológico De Vila Nova De Gaia, Vila Nova Gaia, Portugal

What Does Integration of Services for People who Inject Drugs Mean in Terms of Testing and Providing Treatment? How Does the Health Systems Need to Change to Better Integrate and Can it? Can we Eliminate Hepatitis C Among People Who Inject Drugs on Opioid Substitution Therapy in the Near Future?

5:00 PM - 5:45 PM

Biography

Agenda Item Image
Dr John (Jack) Lambert
Consultant In Infectious Diseases, Medicine And Sexual Health (gum)
UCD/ Mater Misericordiae University Hospital Catherine Mc Auley Education & Research Centre, Dublin, Ireland

What does integration of services for PWID mean in terms of testing and providing treatment? How does the health systems need to change to better integrate and can it? Can we eliminate hepatitis C among PWID on opioid substitution therapy in the near future?

5:00 PM - 5:45 PM

Biography

Jeffrey Lazarus

What does integration of services for PWID mean in terms of testing and providing treatment? How does the health systems need to change to better integrate and can it? Can we eliminate hepatitis C among PWID on opioid substitution therapy in the near future?

5:00 PM - 5:45 PM

Biography

Agenda Item Image
Dr Viktor Mravčík
Researcher
National Monitoring Centre For Drugs And Addiction, Office Of The Government, The Czech Republic

What Does Integration of Services for People who Inject Drugs Mean in Terms of Testing and Providing Treatment? How Does the Health Systems Need to Change to Better Integrate and Can it? Can we Eliminate Hepatitis C Among People Who Inject Drugs on Opioid Substitution Therapy in the Near Future?

5:00 PM - 5:45 PM

Biography

Alistair Story
E-DETECT

What Does Integration of Services for People who Inject Drugs Mean in Terms of Testing and Providing Treatment? How Does the Health Systems Need to Change to Better Integrate and Can it? Can we Eliminate Hepatitis C Among People Who Inject Drugs on Opioid Substitution Therapy in the Near Future?

5:00 PM - 5:45 PM

Biography


Chair

Agenda Item Image
Jeffrey Lazarus
Research Professor
ISGlobal

Jean Luc Sion
DG SANTE

loading